Printer Friendly

Mouse Osteopontin ELISA Now Available from ALPCO.

Salem, NH, May 31, 2013 --(PR.com)-- The second species-specific kit in a line of Osteopontin ELISAs is now available from ALPCO. Following the launch of ALPCO's Human Osteopontin ELISA in April, the new Mouse Osteopontin ELISA will prove to be a valuable addition to the company's bone metabolism and toxicology product portfolios. The assay can be run in three hours with just 5 [micro]L of plasma or serum sample. Other Osteopontin ELISAs for rat and canine will also be released later in 2013.

“We're pleased to launch the second addition to our new line of Osteopontin assays,” says ALPCO President, Sean Conley. “We've heard from the market that there's an unmet need around accurately measuring Mouse Osteopontin, which is why we began developing this new line of products. I'm thrilled that ALPCO is providing solutions to fill the void.”

ALPCO's VP of Scientific Operations, Martin Blankfard, adds, “I'm confident our customers will appreciate our new Osteopontin product line. Researchers will be delighted with the small sample volume and the reduction in assay time compared to most other Osteopontin kits on the market.”

Click here to learn more about the new Mouse Osteopontin ELISA from ALPCO.

About ALPCO

ALPCO (American Laboratory Products Company) was founded in 1991 as a provider of immunoassay kits for the North American research markets. ALPCO's mission is to offer unique product solutions that appeal to a diverse set of customer needs, while providing exceptional customer service and product support. www.alpco.com

Contact Information:

ALPCO Diagnostics

Kelly Scribner-Doering

1-800-592-5726 x222

Contact via Email

www.alpco.com

Read the full story here: http://www.pr.com/press-release/494532
COPYRIGHT 2013 PR.com
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR.com (Press Releases)
Date:May 31, 2013
Words:279
Previous Article:Dr. Abdul Kalam's Lead India 2020 Expands Globally, US Chapter Unveiled an Innovative Model to Engage 25 Million NRIs to Transform India as a...
Next Article:Who Wants to Love Love? Apparently, We All Do. New Indie Author Shows Us That It's Possible to Overcome Tragedy and Find Love When You Least Expect...
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters